| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Stenotrophomonas maltophilia (B715 + L1 + L2) |
- |
- |
>32 － ? |
Meropenem (Merrem)  |
1371 |
| Stenotrophomonas maltophilia (CAN-ICU 62584) |
- |
32 |
? － ? |
Benzalkonium chloride |
1524 |
| Stenotrophomonas maltophilia (GN 12873) |
- |
- |
<0.005 － ? |
N-[3,8-Bis-(2,3-diacetoxybenzoyl)-3,8-diaza-octanoyl]-amoxicillin |
980 |
| Stenotrophomonas maltophilia (GN 12873) |
- |
- |
25 － ? |
Azlocillin |
980 |
| Stenotrophomonas maltophilia (GN 12873) |
- |
- |
>100 － ? |
Ampicillin (Omnipen) |
980 |
| Stenotrophomonas maltophilia (GN 12873) |
- |
- |
>100 － ? |
Meropenem (Merrem) |
980 |
| Stenotrophomonas maltophilia (GN12873 + carbapenem-resistant) |
- |
- |
0.39 － ? |
Levofloxacin (Levaquin, Quixin) |
40 |
| Stenotrophomonas maltophilia (GN12873 + carbapenem-resistant) |
- |
- |
>100 － ? |
Cefdinir (Omnicef, Cefdiel) |
40 |
| Stenotrophomonas maltophilia (GN12873 + carbapenem-resistant) |
- |
- |
>100 － ? |
Faropenem |
40 |
| Stenotrophomonas maltophilia (GN12873 + carbapenem-resistant) |
- |
- |
>100 － ? |
Imipenem |
40 |
| Stenotrophomonas maltophilia (GN12873 + carbapenem-resistant) |
- |
- |
>100 － ? |
LJC 11036 |
40 |
| Stenotrophomonas maltophilia (I-10717) |
- |
- |
2 － ? |
Amphipathic-2D (Peptide) |
296 |
| Stenotrophomonas maltophilia (I-10717) |
- |
- |
4 － ? |
Amphipathic-1D (Peptide) |
296 |
| Stenotrophomonas maltophilia (I-10717) |
- |
- |
>4 － ? |
Amphipathic-3D (Peptide) |
296 |
| Stenotrophomonas maltophilia (I-10717) |
- |
- |
>4 － ? |
Scrambled-4D (Peptide) |
296 |
| Stenotrophomonas maltophilia (I-10717) |
- |
- |
>4 － ? |
Segregated-5D (Peptide) |
296 |
| Stenotrophomonas maltophilia (I-10717) |
- |
- |
>4 － ? |
Segregated-6D (Peptide) |
296 |
| Stenotrophomonas maltophilia (levofloxacin-intermediate) |
64 |
64 |
4 － >64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
| Stenotrophomonas maltophilia (levofloxacin-susceptible) |
0.5 |
1 |
0.03 － 1 |
Moxifloxacin (BAY 12-8039, Avelox) |
1467 |
| Stenotrophomonas maltophilia (levofloxacin-susceptible) |
1 |
2 |
0.12 － 2 |
Levofloxacin (Levaquin, Quixin) |
1467 |
| Stenotrophomonas maltophilia (levofloxacin-susceptible) |
1 |
4 |
0.25 － 8 |
Besifloxacin (Besivance) |
1467 |
| Stenotrophomonas maltophilia (levofloxacin-susceptible) |
2 |
4 |
0.5 － 8 |
Ciprofloxacin (Planktonic) |
1467 |
| Stenotrophomonas maltophilia (levofloxacin-susceptible) |
>8 |
>8 |
>8 － ? |
Imipenem |
1467 |
| Stenotrophomonas maltophilia (levofloxacin-susceptible) |
16 |
>16 |
0.5 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1467 |
| Stenotrophomonas maltophilia (levofloxacin-susceptible) |
16 |
>64 |
1 － >64 |
Tobramycin (Tobrex, Nebcin) |
1467 |
| Stenotrophomonas maltophilia (O-16451) |
- |
- |
>4 － ? |
Amphipathic-1D (Peptide) |
296 |
| Stenotrophomonas maltophilia (O-16451) |
- |
- |
4 － ? |
Amphipathic-2D (Peptide) |
296 |
| Stenotrophomonas maltophilia (O-16451) |
- |
- |
>4 － ? |
Amphipathic-3D (Peptide) |
296 |